Cargando…

The prognostic value of four interleukin-1 gene polymorphisms in caucasian women with breast cancer – a multicenter study

BACKGROUND: The proinflammatory cytokine interleukin-1 (IL-1) is known to play an important role in the carcinogenesis of breast cancer. Although IL-1 gene polymorphisms were reported to be associated with increased risk of breast cancer, their influence on survival of Caucasian breast cancer patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grimm, Christoph, Kantelhardt, Eva, Heinze, Georg, Polterauer, Stephan, Zeillinger, Robert, Kölbl, Heinz, Reinthaller, Alexander, Hefler, Lukas
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656545/ https://www.ncbi.nlm.nih.gov/pubmed/19267917 http://dx.doi.org/10.1186/1471-2407-9-78

Ejemplares similares

Prognostic role of plasma fibrinogen in patients with uterine leiomyosarcoma – a multicenter study
por: Bekos, Christine, et al.
Publicado: (2017)

Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma
por: Schwameis, Richard, et al.
Publicado: (2016)

Prognostic value of serum creatine level in patients with vulvar cancer
por: Schwameis, Richard, et al.
Publicado: (2019)

The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study
por: Seebacher, Veronika, et al.
Publicado: (2009)

The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial
por: Seebacher, V, et al.
Publicado: (2010)

Association of TAP Gene Polymorphisms and Risk of Cervical Intraepithelial Neoplasia
por: Natter, Camilla, et al.
Publicado: (2013)

Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real‐World Precision Cancer Medicine Platform
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

The impact of lymph node density on survival of cervical cancer patients
por: Polterauer, S, et al.
Publicado: (2010)

The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy
por: Poetsch, Nina, et al.
Publicado: (2019)

The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma
por: Schwameis, Richard, et al.
Publicado: (2015)

Factors associated with post-relapse survival in patients with recurrent cervical cancer: the value of the inflammation-based Glasgow Prognostic Score
por: Seebacher, Veronika, et al.
Publicado: (2018)

Natural history of cervical intraepithelial neoplasia in pregnancy: postpartum histo-pathologic outcome and review of the literature
por: Mailath-Pokorny, Mariella, et al.
Publicado: (2016)

Reply: Lymph node density as a surrogate marker for positive lymph nodes
por: Polterauer, S, et al.
Publicado: (2011)

A collagen-fibrin patch (Tachosil®) for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: a randomized clinical trial
por: Grimm, Christoph, et al.
Publicado: (2014)

The Pretreatment Controlling Nutritional Status Score in Ovarian Cancer: Influence on Prognosis, Surgical Outcome, and Postoperative Complication Rate
por: Bekos, Christine, et al.
Publicado: (2022)

Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis
por: Bekos, Christine, et al.
Publicado: (2018)

Development of a tool for prediction of ovarian cancer in patients with adnexal masses: Value of plasma fibrinogen
por: Seebacher, Veronika, et al.
Publicado: (2017)

The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer
por: Aust, Stefanie, et al.
Publicado: (2013)

The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer – A Retrospective Study
por: Seebacher, Veronika, et al.
Publicado: (2017)

Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report
por: Paspalj, V., et al.
Publicado: (2021)

Nomogram prediction for overall survival of patients diagnosed with cervical cancer
por: Polterauer, S, et al.
Publicado: (2012)

The Prognostic Value of the Fibrinogen-Albumin-Ratio Index (FARI) in Patients with Advanced Vulvar Cancer
por: Onoprienko, Arina, et al.
Publicado: (2022)

Joint Guideline of the OEGGG, AGO, AGK and ÖGZ on the Diagnosis and Treatment of Cervical Intraepithelial Neoplasia and Appropriate Procedures When Cytological Specimens Are Unsatisfactory
por: Reich, Olaf, et al.
Publicado: (2018)

Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients
por: Grech, Christina T., et al.
Publicado: (2022)

Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer
por: Grimm, C, et al.
Publicado: (2013)

Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients
por: Hefler, L, et al.
Publicado: (1999)

AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer – a retrospective multi-centre study
por: Seebacher, Veronika, et al.
Publicado: (2018)

Current evidence on the four polymorphisms of VDR and breast cancer risk in Caucasian women()
por: Yang, Baohong, et al.
Publicado: (2013)

Increased genitourinary fistula rate after bevacizumab in recurrent cervical cancer patients initially treated with definitive radiochemotherapy and image-guided adaptive brachytherapy
por: Sturdza, Alina, et al.
Publicado: (2017)

Pre-operative hypoalbuminemia is associated with complication rate and overall survival in patients with vulvar cancer undergoing surgery
por: Bekos, Christine, et al.
Publicado: (2019)

Impact of frailty on the management of patients with gynecological cancer aged 80 years and older
por: Reiser, Elisabeth, et al.
Publicado: (2020)

The prognostic value of CD44 isoform expression in endometrial cancer.
por: Tempfer, C., et al.
Publicado: (1998)

In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway
por: Pils, D, et al.
Publicado: (2007)

Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer
por: Aust, Stefanie, et al.
Publicado: (2015)

Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data
por: Oberndorfer, Felicitas, et al.
Publicado: (2021)

Common Oxytocin Receptor Gene Polymorphisms and the Risk for Preterm Birth
por: Kuessel, Lorenz, et al.
Publicado: (2013)

Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium
por: Bachmayr-Heyda, Anna, et al.
Publicado: (2013)

Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer
por: Tsibulak, Irina, et al.
Publicado: (2022)

Precision Medicine Tumor Boards: Clinical Applicability of Personalized Treatment Concepts in Ovarian Cancer
por: Aust, Stefanie, et al.
Publicado: (2020)

Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma
por: Lamm, Wolfgang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_63k7isned0ipoh5a54ib4sacmg